. 2017 Jul-Sep;6(3):102–105. doi: 10.4103/sajc.sajc_113_17
Copyright: © 2017 The South Asian Journal of Cancer
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Figure 1.
Mechanistic target of rapamycin progression-free survival